Search

Eyewire News: The Podcast

Eyewire News: The Podcast

06.04.25

Alcon Gains FDA Approval for Novel DED Drug

Alcon receives FDA approval for a novel pharmaceutical treatment for dry eye disease; Genentech’s Susvimo ocular implant is approval for a third indication in the US; and the makers of two investigational treatments for wet AMD complete enrollment in their respective phase 3 trials. Learn more about your ad choices. Visit megaphone.fm/adchoices

View full description +

MORE EPISODES

09.03.25

Update on Investigational Treatments for Retinal Diseases

08.27.25

CE Certification for New Glaucoma Surgical Implant

08.20.25

Special Report: TFOS DEWS III Leaders Discuss New DED Guidance

08.13.25

First Commerical Surgeries Performed with MacTel Therapy

08.06.25

Alcon Acquires Staar for $1.5 Billion

07.30.25

Tryptyr Now Available in US

07.23.25

Harrow Adds Biosimilars to US Portfolio

07.16.25

AECOS Presentation Summaries

Show More

Anterior 3D Cataract Cornea General Glaucoma Optometry Pediatric Refractive/LVC Residents & Fellows Retina Retina 3D